特発性肺線維症において高いS100A9レベルは生存率の低さを予測し、S100A9阻害薬であるパキニモドは特発性肺線維症治療の選択肢となり得る

Material type: 博士論文

Author: 三浦, 慎一朗

Publisher: -

Publication date: -

Material Format: Digital

Capacity, size, etc.: -

Name of awarding university/degree: 広島大学,Hiroshima University,博士(医学),Doctor of Philosophy in Medical Science

View All

Related materials as well as pre- and post-revision versions

BMJ Open Respir Res 2024:11:e001803.

Search by Bookstore

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

List of Cooperating Institutions and Databases

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

Hiroshima University Institutional Repository
Digital
You can check the holdings of institutions and databases with which Institutional Repositories DataBase(IRDB)(Institutional Repository) is linked at the site of Institutional Repositories DataBase(IRDB)(Institutional Repository).
Hiroshima University Institutional Repository

Search by Bookstore

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type: 博士論文
Title: 特発性肺線維症において高いS100A9レベルは生存率の低さを予測し、S100A9阻害薬であるパキニモドは特発性肺線維症治療の選択肢となり得る
Author/Editor: 三浦, 慎一朗
Author Heading: 三浦, 慎一朗
Alternative Title: High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis
Degree grantor/type: 広島大学
Hiroshima University
Date Granted: 2024-05-23
Dissertation Number: 甲第9607号
Degree Type: 博士(医学)
Doctor of Philosophy in Medical Science
Text Language Code: eng
Target Audience: 一般
Format (IMT): application/pdf
Source: fulltext
http://ir.lib.hiroshima-u.ac.jp/55992/files/49690
Access Restrictions: インターネット公開
Rights (production): © by author. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Related Material: BMJ Open Respir Res 2024:11:e001803.
Related Material (DOI): 10.1136/bmjresp-2023-001803
Data Provider (Database): 国立情報学研究所 : 学術機関リポジトリデータベース（IRDB）（機関リポジトリ）
https://irdb.nii.ac.jp
Original Data Provider (Database): 広島大学 : 広島大学学術情報リポジトリ